The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Transcriptome Sequencing Based on RNA-seq Market Research Report 2024

Global Transcriptome Sequencing Based on RNA-seq Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1737724

No of Pages : 84

Synopsis
Transcriptome sequencing, also known as RNA sequencing (RNA-seq), is a high-throughput sequencing technique used to analyze and quantify the entire set of RNA molecules (transcripts) present in a cell or tissue sample.
Global Transcriptome Sequencing Based on RNA-seq market is projected to reach US$ 6002.9 million in 2029, increasing from US$ 2701 million in 2022, with the CAGR of 12.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Transcriptome Sequencing Based on RNA-seq market research.
Key companies engaged in the Transcriptome Sequencing Based on RNA-seq industry include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories and Fluidigm, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Transcriptome Sequencing Based on RNA-seq were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Transcriptome Sequencing Based on RNA-seq market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Transcriptome Sequencing Based on RNA-seq market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
High-throughput
Low-throughput
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Transcriptome Sequencing Based on RNA-seq report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transcriptome Sequencing Based on RNA-seq Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 High-throughput
1.2.3 Low-throughput
1.3 Market by Application
1.3.1 Global Transcriptome Sequencing Based on RNA-seq Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transcriptome Sequencing Based on RNA-seq Market Perspective (2018-2029)
2.2 Transcriptome Sequencing Based on RNA-seq Growth Trends by Region
2.2.1 Global Transcriptome Sequencing Based on RNA-seq Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Transcriptome Sequencing Based on RNA-seq Historic Market Size by Region (2018-2023)
2.2.3 Transcriptome Sequencing Based on RNA-seq Forecasted Market Size by Region (2024-2029)
2.3 Transcriptome Sequencing Based on RNA-seq Market Dynamics
2.3.1 Transcriptome Sequencing Based on RNA-seq Industry Trends
2.3.2 Transcriptome Sequencing Based on RNA-seq Market Drivers
2.3.3 Transcriptome Sequencing Based on RNA-seq Market Challenges
2.3.4 Transcriptome Sequencing Based on RNA-seq Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transcriptome Sequencing Based on RNA-seq Players by Revenue
3.1.1 Global Top Transcriptome Sequencing Based on RNA-seq Players by Revenue (2018-2023)
3.1.2 Global Transcriptome Sequencing Based on RNA-seq Revenue Market Share by Players (2018-2023)
3.2 Global Transcriptome Sequencing Based on RNA-seq Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transcriptome Sequencing Based on RNA-seq Revenue
3.4 Global Transcriptome Sequencing Based on RNA-seq Market Concentration Ratio
3.4.1 Global Transcriptome Sequencing Based on RNA-seq Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcriptome Sequencing Based on RNA-seq Revenue in 2022
3.5 Transcriptome Sequencing Based on RNA-seq Key Players Head office and Area Served
3.6 Key Players Transcriptome Sequencing Based on RNA-seq Product Solution and Service
3.7 Date of Enter into Transcriptome Sequencing Based on RNA-seq Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transcriptome Sequencing Based on RNA-seq Breakdown Data by Type
4.1 Global Transcriptome Sequencing Based on RNA-seq Historic Market Size by Type (2018-2023)
4.2 Global Transcriptome Sequencing Based on RNA-seq Forecasted Market Size by Type (2024-2029)
5 Transcriptome Sequencing Based on RNA-seq Breakdown Data by Application
5.1 Global Transcriptome Sequencing Based on RNA-seq Historic Market Size by Application (2018-2023)
5.2 Global Transcriptome Sequencing Based on RNA-seq Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Transcriptome Sequencing Based on RNA-seq Market Size (2018-2029)
6.2 North America Transcriptome Sequencing Based on RNA-seq Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Transcriptome Sequencing Based on RNA-seq Market Size by Country (2018-2023)
6.4 North America Transcriptome Sequencing Based on RNA-seq Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transcriptome Sequencing Based on RNA-seq Market Size (2018-2029)
7.2 Europe Transcriptome Sequencing Based on RNA-seq Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Transcriptome Sequencing Based on RNA-seq Market Size by Country (2018-2023)
7.4 Europe Transcriptome Sequencing Based on RNA-seq Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transcriptome Sequencing Based on RNA-seq Market Size (2018-2029)
8.2 Asia-Pacific Transcriptome Sequencing Based on RNA-seq Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Transcriptome Sequencing Based on RNA-seq Market Size by Region (2018-2023)
8.4 Asia-Pacific Transcriptome Sequencing Based on RNA-seq Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transcriptome Sequencing Based on RNA-seq Market Size (2018-2029)
9.2 Latin America Transcriptome Sequencing Based on RNA-seq Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Transcriptome Sequencing Based on RNA-seq Market Size by Country (2018-2023)
9.4 Latin America Transcriptome Sequencing Based on RNA-seq Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transcriptome Sequencing Based on RNA-seq Market Size (2018-2029)
10.2 Middle East & Africa Transcriptome Sequencing Based on RNA-seq Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Transcriptome Sequencing Based on RNA-seq Market Size by Country (2018-2023)
10.4 Middle East & Africa Transcriptome Sequencing Based on RNA-seq Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Transcriptome Sequencing Based on RNA-seq Introduction
11.1.4 Thermo Fisher Scientific Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina Transcriptome Sequencing Based on RNA-seq Introduction
11.2.4 Illumina Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.2.5 Illumina Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Detail
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Transcriptome Sequencing Based on RNA-seq Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Transcriptome Sequencing Based on RNA-seq Introduction
11.4.4 Agilent Technologies Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Transcriptome Sequencing Based on RNA-seq Introduction
11.5.4 Roche Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.5.5 Roche Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Transcriptome Sequencing Based on RNA-seq Introduction
11.6.4 GE Healthcare Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.6.5 GE Healthcare Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Transcriptome Sequencing Based on RNA-seq Introduction
11.7.4 Bio-Rad Laboratories Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Fluidigm
11.8.1 Fluidigm Company Detail
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm Transcriptome Sequencing Based on RNA-seq Introduction
11.8.4 Fluidigm Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.8.5 Fluidigm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’